Global Cell Immunotherapy Platform Supply, Demand and Key Producers, 2024-2030

Page: 107

Published Date: 19 Nov 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Cell Immunotherapy Platform market size is expected to reach $ 8103 million by 2030, rising at a market growth of 17.1% CAGR during the forecast period (2024-2030).

The cell immunotherapy platform is a technology platform that uses the patient's own or donor's immune cells, which are cultured, activated, modified or amplified in vitro and then reinfused into the body to treat diseases. The platform activates or enhances the function of the immune system, enabling it to recognize and attack tumor cells, viral infections or other abnormal cells. Common cell immunotherapy methods include CAR-T cell therapy, T cell therapy and dendritic cell vaccines. This platform provides new treatment ideas and means for the treatment of cancer, autoimmune diseases, etc.

This report studies the global Cell Immunotherapy Platform demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell Immunotherapy Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Immunotherapy Platform that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell Immunotherapy Platform total market, 2019-2030, (USD Million)
Global Cell Immunotherapy Platform total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell Immunotherapy Platform total market, key domestic companies, and share, (USD Million)
Global Cell Immunotherapy Platform revenue by player, revenue and market share 2019-2024, (USD Million)
Global Cell Immunotherapy Platform total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell Immunotherapy Platform total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Cell Immunotherapy Platform market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech, Celltrion, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell Immunotherapy Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell Immunotherapy Platform Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell Immunotherapy Platform Market, Segmentation by Type
Autologous Immune Cell Therapy
Allogeneic Immune Cell Therapy

Global Cell Immunotherapy Platform Market, Segmentation by Application:
Immunotherapy Industry
Biopharmaceutical Industry
Others

Companies Profiled:
Kite Pharma
Novartis
Bristol Myers Squibb
Gilead Sciences
Bluebird Bio
Celyad Oncology
Autolus Therapeutics
Legend Biotech
Celltrion

Key Questions Answered
1. How big is the global Cell Immunotherapy Platform market?
2. What is the demand of the global Cell Immunotherapy Platform market?
3. What is the year over year growth of the global Cell Immunotherapy Platform market?
4. What is the total value of the global Cell Immunotherapy Platform market?
5. Who are the Major Players in the global Cell Immunotherapy Platform market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell Immunotherapy Platform Introduction
    1.2 World Cell Immunotherapy Platform Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell Immunotherapy Platform Total Market by Region (by Headquarter Location)
        1.3.1 World Cell Immunotherapy Platform Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.3 China Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.4 Europe Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.5 Japan Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.6 South Korea Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.7 ASEAN Based Company Cell Immunotherapy Platform Revenue (2019-2030)
        1.3.8 India Based Company Cell Immunotherapy Platform Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell Immunotherapy Platform Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.2 World Cell Immunotherapy Platform Consumption Value by Region
        2.2.1 World Cell Immunotherapy Platform Consumption Value by Region (2019-2024)
        2.2.2 World Cell Immunotherapy Platform Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.4 China Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.5 Europe Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.6 Japan Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.7 South Korea Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.8 ASEAN Cell Immunotherapy Platform Consumption Value (2019-2030)
    2.9 India Cell Immunotherapy Platform Consumption Value (2019-2030)

3 World Cell Immunotherapy Platform Companies Competitive Analysis
    3.1 World Cell Immunotherapy Platform Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell Immunotherapy Platform Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell Immunotherapy Platform in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell Immunotherapy Platform in 2023
    3.3 Cell Immunotherapy Platform Company Evaluation Quadrant
    3.4 Cell Immunotherapy Platform Market: Overall Company Footprint Analysis
        3.4.1 Cell Immunotherapy Platform Market: Region Footprint
        3.4.2 Cell Immunotherapy Platform Market: Company Product Type Footprint
        3.4.3 Cell Immunotherapy Platform Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Cell Immunotherapy Platform Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell Immunotherapy Platform Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell Immunotherapy Platform Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell Immunotherapy Platform Consumption Value Comparison
        4.2.1 United States VS China: Cell Immunotherapy Platform Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell Immunotherapy Platform Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell Immunotherapy Platform Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell Immunotherapy Platform Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell Immunotherapy Platform Revenue, (2019-2024)
    4.4 China Based Companies Cell Immunotherapy Platform Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell Immunotherapy Platform Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell Immunotherapy Platform Revenue, (2019-2024)
    4.5 Rest of World Based Cell Immunotherapy Platform Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell Immunotherapy Platform Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Cell Immunotherapy Platform Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Cell Immunotherapy Platform Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Autologous Immune Cell Therapy
        5.2.2 Allogeneic Immune Cell Therapy
    5.3 Market Segment by Type
        5.3.1 World Cell Immunotherapy Platform Market Size by Type (2019-2024)
        5.3.2 World Cell Immunotherapy Platform Market Size by Type (2025-2030)
        5.3.3 World Cell Immunotherapy Platform Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Cell Immunotherapy Platform Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Immunotherapy Industry
        6.2.2 Biopharmaceutical Industry
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Cell Immunotherapy Platform Market Size by Application (2019-2024)
        6.3.2 World Cell Immunotherapy Platform Market Size by Application (2025-2030)
        6.3.3 World Cell Immunotherapy Platform Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Kite Pharma
        7.1.1 Kite Pharma Details
        7.1.2 Kite Pharma Major Business
        7.1.3 Kite Pharma Cell Immunotherapy Platform Product and Services
        7.1.4 Kite Pharma Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Kite Pharma Recent Developments/Updates
        7.1.6 Kite Pharma Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Cell Immunotherapy Platform Product and Services
        7.2.4 Novartis Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Bristol Myers Squibb
        7.3.1 Bristol Myers Squibb Details
        7.3.2 Bristol Myers Squibb Major Business
        7.3.3 Bristol Myers Squibb Cell Immunotherapy Platform Product and Services
        7.3.4 Bristol Myers Squibb Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bristol Myers Squibb Recent Developments/Updates
        7.3.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.4 Gilead Sciences
        7.4.1 Gilead Sciences Details
        7.4.2 Gilead Sciences Major Business
        7.4.3 Gilead Sciences Cell Immunotherapy Platform Product and Services
        7.4.4 Gilead Sciences Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Gilead Sciences Recent Developments/Updates
        7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.5 Bluebird Bio
        7.5.1 Bluebird Bio Details
        7.5.2 Bluebird Bio Major Business
        7.5.3 Bluebird Bio Cell Immunotherapy Platform Product and Services
        7.5.4 Bluebird Bio Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Bluebird Bio Recent Developments/Updates
        7.5.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.6 Celyad Oncology
        7.6.1 Celyad Oncology Details
        7.6.2 Celyad Oncology Major Business
        7.6.3 Celyad Oncology Cell Immunotherapy Platform Product and Services
        7.6.4 Celyad Oncology Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Celyad Oncology Recent Developments/Updates
        7.6.6 Celyad Oncology Competitive Strengths & Weaknesses
    7.7 Autolus Therapeutics
        7.7.1 Autolus Therapeutics Details
        7.7.2 Autolus Therapeutics Major Business
        7.7.3 Autolus Therapeutics Cell Immunotherapy Platform Product and Services
        7.7.4 Autolus Therapeutics Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Autolus Therapeutics Recent Developments/Updates
        7.7.6 Autolus Therapeutics Competitive Strengths & Weaknesses
    7.8 Legend Biotech
        7.8.1 Legend Biotech Details
        7.8.2 Legend Biotech Major Business
        7.8.3 Legend Biotech Cell Immunotherapy Platform Product and Services
        7.8.4 Legend Biotech Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Legend Biotech Recent Developments/Updates
        7.8.6 Legend Biotech Competitive Strengths & Weaknesses
    7.9 Celltrion
        7.9.1 Celltrion Details
        7.9.2 Celltrion Major Business
        7.9.3 Celltrion Cell Immunotherapy Platform Product and Services
        7.9.4 Celltrion Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Celltrion Recent Developments/Updates
        7.9.6 Celltrion Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell Immunotherapy Platform Industry Chain
    8.2 Cell Immunotherapy Platform Upstream Analysis
    8.3 Cell Immunotherapy Platform Midstream Analysis
    8.4 Cell Immunotherapy Platform Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Cell Immunotherapy Platform Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Cell Immunotherapy Platform Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Cell Immunotherapy Platform Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Cell Immunotherapy Platform Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Cell Immunotherapy Platform Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Cell Immunotherapy Platform Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Cell Immunotherapy Platform Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Cell Immunotherapy Platform Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Cell Immunotherapy Platform Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Cell Immunotherapy Platform Players in 2023
 Table 12. World Cell Immunotherapy Platform Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Cell Immunotherapy Platform Company Evaluation Quadrant
 Table 14. Head Office of Key Cell Immunotherapy Platform Players
 Table 15. Cell Immunotherapy Platform Market: Company Product Type Footprint
 Table 16. Cell Immunotherapy Platform Market: Company Product Application Footprint
 Table 17. Cell Immunotherapy Platform Mergers & Acquisitions Activity
 Table 18. United States VS China Cell Immunotherapy Platform Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Cell Immunotherapy Platform Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Cell Immunotherapy Platform Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Cell Immunotherapy Platform Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Cell Immunotherapy Platform Revenue Market Share (2019-2024)
 Table 23. China Based Cell Immunotherapy Platform Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Cell Immunotherapy Platform Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Cell Immunotherapy Platform Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Cell Immunotherapy Platform Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Cell Immunotherapy Platform Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Cell Immunotherapy Platform Revenue Market Share (2019-2024)
 Table 29. World Cell Immunotherapy Platform Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Cell Immunotherapy Platform Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Cell Immunotherapy Platform Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Cell Immunotherapy Platform Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Cell Immunotherapy Platform Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Cell Immunotherapy Platform Market Size by Application (2025-2030) & (USD Million)
 Table 35. Kite Pharma Basic Information, Manufacturing Base and Competitors
 Table 36. Kite Pharma Major Business
 Table 37. Kite Pharma Cell Immunotherapy Platform Product and Services
 Table 38. Kite Pharma Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Kite Pharma Recent Developments/Updates
 Table 40. Kite Pharma Competitive Strengths & Weaknesses
 Table 41. Novartis Basic Information, Manufacturing Base and Competitors
 Table 42. Novartis Major Business
 Table 43. Novartis Cell Immunotherapy Platform Product and Services
 Table 44. Novartis Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Novartis Recent Developments/Updates
 Table 46. Novartis Competitive Strengths & Weaknesses
 Table 47. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 48. Bristol Myers Squibb Major Business
 Table 49. Bristol Myers Squibb Cell Immunotherapy Platform Product and Services
 Table 50. Bristol Myers Squibb Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Bristol Myers Squibb Recent Developments/Updates
 Table 52. Bristol Myers Squibb Competitive Strengths & Weaknesses
 Table 53. Gilead Sciences Basic Information, Manufacturing Base and Competitors
 Table 54. Gilead Sciences Major Business
 Table 55. Gilead Sciences Cell Immunotherapy Platform Product and Services
 Table 56. Gilead Sciences Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Gilead Sciences Recent Developments/Updates
 Table 58. Gilead Sciences Competitive Strengths & Weaknesses
 Table 59. Bluebird Bio Basic Information, Manufacturing Base and Competitors
 Table 60. Bluebird Bio Major Business
 Table 61. Bluebird Bio Cell Immunotherapy Platform Product and Services
 Table 62. Bluebird Bio Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Bluebird Bio Recent Developments/Updates
 Table 64. Bluebird Bio Competitive Strengths & Weaknesses
 Table 65. Celyad Oncology Basic Information, Manufacturing Base and Competitors
 Table 66. Celyad Oncology Major Business
 Table 67. Celyad Oncology Cell Immunotherapy Platform Product and Services
 Table 68. Celyad Oncology Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Celyad Oncology Recent Developments/Updates
 Table 70. Celyad Oncology Competitive Strengths & Weaknesses
 Table 71. Autolus Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 72. Autolus Therapeutics Major Business
 Table 73. Autolus Therapeutics Cell Immunotherapy Platform Product and Services
 Table 74. Autolus Therapeutics Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Autolus Therapeutics Recent Developments/Updates
 Table 76. Autolus Therapeutics Competitive Strengths & Weaknesses
 Table 77. Legend Biotech Basic Information, Manufacturing Base and Competitors
 Table 78. Legend Biotech Major Business
 Table 79. Legend Biotech Cell Immunotherapy Platform Product and Services
 Table 80. Legend Biotech Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Legend Biotech Recent Developments/Updates
 Table 82. Legend Biotech Competitive Strengths & Weaknesses
 Table 83. Celltrion Basic Information, Manufacturing Base and Competitors
 Table 84. Celltrion Major Business
 Table 85. Celltrion Cell Immunotherapy Platform Product and Services
 Table 86. Celltrion Cell Immunotherapy Platform Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Celltrion Recent Developments/Updates
 Table 88. Celltrion Competitive Strengths & Weaknesses
 Table 89. Global Key Players of Cell Immunotherapy Platform Upstream (Raw Materials)
 Table 90. Global Cell Immunotherapy Platform Typical Customers


List of Figures
 Figure 1. Cell Immunotherapy Platform Picture
 Figure 2. World Cell Immunotherapy Platform Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Cell Immunotherapy Platform Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Cell Immunotherapy Platform Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Cell Immunotherapy Platform Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Cell Immunotherapy Platform Revenue (2019-2030) & (USD Million)
 Figure 13. Cell Immunotherapy Platform Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Cell Immunotherapy Platform Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Cell Immunotherapy Platform Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Cell Immunotherapy Platform by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Immunotherapy Platform Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Immunotherapy Platform Markets in 2023
 Figure 27. United States VS China: Cell Immunotherapy Platform Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Cell Immunotherapy Platform Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Cell Immunotherapy Platform Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Cell Immunotherapy Platform Market Size Market Share by Type in 2023
 Figure 31. Autologous Immune Cell Therapy
 Figure 32. Allogeneic Immune Cell Therapy
 Figure 33. World Cell Immunotherapy Platform Market Size Market Share by Type (2019-2030)
 Figure 34. World Cell Immunotherapy Platform Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Cell Immunotherapy Platform Market Size Market Share by Application in 2023
 Figure 36. Immunotherapy Industry
 Figure 37. Biopharmaceutical Industry
 Figure 38. Others
 Figure 39. World Cell Immunotherapy Platform Market Size Market Share by Application (2019-2030)
 Figure 40. Cell Immunotherapy Platform Industrial Chain
 Figure 41. Methodology
 Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Kite Pharma
Novartis
Bristol Myers Squibb
Gilead Sciences
Bluebird Bio
Celyad Oncology
Autolus Therapeutics
Legend Biotech
Celltrion

Related Reports

Global Cell Immunotherapy Platform Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell Immunotherapy Platform Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 19 Nov 2024

date Service & Software

According to our (Global Info Research) latest study, the global Cell Immunotherapy Platform market size was valued at US$ 2676 million in 2023 and is forecast to a readjusted size of USD 8103 million by 2030 with a CAGR of 17.1% during review period.

Product Tags

Cell Immunotherapy Platform

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>